Skip to main content

Sotera Health Co

corporate_fare Company Profile

Sotera Health Co

SHC·NASDAQ·Industrial Applications And Services·CIK 0001822479

We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. Our mission is Safeguarding Global Health®. We provide these services to ensure medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers in the United States and globally. In 2025, our customer base included over 40 of the top 50 medical device companies and nine of the top ten global pharmaceutical companies (based on revenue). Our services are crucial to our customers' manufacturing processes and supply chains, helping sterilized medical products reach healthcare practitioners and patients. Most of our services are required for customers to meet government regulations. We partner with customers in over 50 countries, aiming to ensure their products meet regulatory, safety, and effectiveness requirements. With our scientific and technological expertise, we contribute to the safety of millions of patients and healthcare practitioners worldwide. We operate 62 facilities globally and have over 3,000 employees focused on safety and quality. Our Sterilization Services business includes Sterigenics and Nordion. Sterigenics is a leading global provider of outsourced terminal sterilization and irradiation services, with over 90 years of experience. We offer a globally integrated platform for customers in the medical device, pharmaceutical, food safety, and advanced applications markets, with facilities located near manufacturing sites and distribution hubs. Terminal sterilization, an essential and often government-mandated final step, sterilizes a product in its final packaging before shipment. Products we sterilize include procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers (including PPE), laboratory products, and pharmaceuticals.

Sotera Health Co (NASDAQ:SHC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for SHC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Sotera Health Reports Strong 2025 Financial Results, Positive 2026 Outlook, and Smooth General Counsel Transition
  • Sotera Health Appoints Former Timken CEO Richard Kyle to Board of Directors

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.16B
Net Income
$77.95M
Diluted EPS
$0.27
Op. Cash Flow
$287.19M
Free Cash Flow
$149.18M
Gross Profit
$645.53M
Cash & Equivalents
$344.62M
Total Debt
$2.14B
Debt / Equity
3.53×
Net Margin
6.7%
Shares Outstanding
283.96M sh
Source: 10-K · filed 2026-02-24 · accession 0001822479-26-000015
$18.69
52-week range · as of 2026-08-17 $13.09 – $19.85
Market cap
$5.33B
Volume
1.5M (0.6× avg)
3-mo avg 2.4M
Live data · 2026-09-22 20:17 UTC · After hours

show_chartPrice Chart

Loading chart...

feed SHC - Filings & News (Page 2)

SHC
Feb 24, 2026, 7:14 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.75
Real-time Price: $18.69 info
Change: +$0.940 (+5%) info
Market Cap: $5.334B info
SHC
Feb 05, 2026, 7:35 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $17.85
Real-time Price: $18.69 info
Change: +$0.840 (+5%) info
Market Cap: $5.334B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets